Alan Chorlton

Alan Chorlton is a notable inventor based in Great Britain. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of solvate compositions and cocrystals. His work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Alan Chorlton's latest patents include compositions and cocrystals of Aprepitant L-Proline. These inventions encompass a range of formulations, such as a 1:1:1 aprepitant L-proline methanol composition and its corresponding cocrystal. Additionally, he has developed similar compositions using ethanol and n-propanol. These formulations are designed to treat or prevent disorders related to emesis, neuropsychiatric diseases, inflammatory diseases, pain, cancer, skin diseases, respiratory diseases, and addictions.

Career Highlights

Chorlton is currently associated with Nuformix Technologies Limited, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in creating effective treatments that address complex health issues.

Collaborations

Some of his notable coworkers include Joanne Holland and Christopher Frampton. Their collaborative efforts contribute to the innovative environment at Nuformix Technologies Limited.

Conclusion

Alan Chorlton's contributions to pharmaceutical compositions highlight his commitment to innovation in the medical field. His work on Aprepitant L-Proline compositions and cocrystals showcases the potential for new treatments for various disorders.

Profile summary based on public USPTO records.